Addtech acquires a Finnish diagnostics company
Addtech Life Science, a business area in the Addtech Group, has today signed an agreement to acquire all shares outstanding in Immuno Diagnostic Oy.
Immuno Diagnostic Oy sells diagnostic and research reagents to hospital laboratories, medical schools, universities and to the pharmaceutical industry. The company has a strong position on the Finnish market and represents leading suppliers in the field of immunology and molecular biology. The company has ten employees and revenue of approximately EUR 4 million.
Immuno Diagnostic Oy constitutes an excellent compliment to Addtech’s operations within the business unit Diagnostics. This business unit focuses on sales of reagents and equipment for hospital laboratories in the entire Nordic Region.
The closing will be on the 31 of May 2010 and the acquisition is estimated to have a marginally positive effect on Addtech’s earnings per share during the current financial year.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.